首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1975篇
  免费   197篇
  国内免费   35篇
耳鼻咽喉   31篇
儿科学   64篇
妇产科学   6篇
基础医学   719篇
口腔科学   29篇
临床医学   145篇
内科学   399篇
皮肤病学   50篇
神经病学   41篇
特种医学   42篇
外科学   66篇
综合类   155篇
现状与发展   1篇
预防医学   152篇
眼科学   19篇
药学   155篇
  1篇
中国医学   70篇
肿瘤学   62篇
  2024年   2篇
  2023年   47篇
  2022年   54篇
  2021年   121篇
  2020年   106篇
  2019年   107篇
  2018年   88篇
  2017年   81篇
  2016年   73篇
  2015年   44篇
  2014年   105篇
  2013年   132篇
  2012年   78篇
  2011年   89篇
  2010年   67篇
  2009年   78篇
  2008年   77篇
  2007年   69篇
  2006年   58篇
  2005年   85篇
  2004年   71篇
  2003年   55篇
  2002年   59篇
  2001年   62篇
  2000年   51篇
  1999年   56篇
  1998年   35篇
  1997年   37篇
  1996年   37篇
  1995年   31篇
  1994年   14篇
  1993年   14篇
  1992年   19篇
  1991年   9篇
  1990年   9篇
  1989年   6篇
  1988年   7篇
  1987年   11篇
  1986年   3篇
  1985年   13篇
  1984年   11篇
  1983年   6篇
  1982年   5篇
  1981年   9篇
  1980年   7篇
  1979年   1篇
  1978年   4篇
  1977年   1篇
  1976年   2篇
  1975年   1篇
排序方式: 共有2207条查询结果,搜索用时 343 毫秒
1.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context.  相似文献   
2.
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients.  相似文献   
3.
目的了解SysmexXE-2100全自动血细胞分析仪嗜酸性粒细胞绝对值计数的准确性。方法分别用仪器法和目测法计数60份抗凝静脉血的嗜酸性粒细胞数,再将两者的结果进行比较;并对5份嗜酸性粒细胞数值不同的抗凝静脉血分别用仪器法和目测法计数,每份标本重复计数10次,然后计算出CV值进行比较。结果60份抗凝静脉血仪器法和目测法计数结果之间无显著性差异,P>0.05;相关系数(r)为0.9996,P<0.01。仪器法和目测法对5份嗜酸性粒细胞数值不同的标本重复计数的平均CV值分别是1.98%和6.63%,显示仪器法的精密度明显高于目测法。结论用SysmexSE-2100全自动血细胞分析仪计数嗜酸性粒细胞绝对值(0~9.02×109/L)是一种快速和较准确的方法,可满足临床诊断、治疗和疗效观察的需要。  相似文献   
4.
Th2细胞因子调节哮喘炎症细胞转运机制的研究   总被引:1,自引:0,他引:1  
目的 探讨Th2细胞因子IL-5、IL-13调节哮喘炎症过程中肺和骨髓之间的细胞转运机制。方法 建立哮喘动物模型,获取肺泡灌洗液,检测IL-5、IFN-γ,浓度并进行病理分析;应用原位杂交技术检测肺组织IL-5、IL-13 mRNA表达和骨髓IL-5mRNA表达;免疫组化法观察肺、骨髓IL-5免疫反应细胞;流式细胞仪检测骨髓CD34、CD3阳性细胞。结果 哮喘组肺泡灌洗液IL-5浓度明显高于对照组(P<0.001);哮喘组肺组织病理改变显示小气道痉挛,管壁周围炎性细胞浸润,以嗜酸粒细胞、淋巴细胞为主;哮喘组肺组织IL-5、IL-13 mRNA表达较对照组显著增加(P<0.01);哮喘组骨髓IL-5 mRNA阳性细胞明显增加(P<0.001),与肺组织IL-5 mRNA表达的增高密切相关(P<0.05);此外,哮喘组肺组织和骨髓IL-5免疫反应细胞显著增加(P<0.01),骨髓CD34、CD3细胞均显著增高(P<0.01),并且CD34增高与骨髓细胞表达IL-5 mRNA密切相关(P<0.05)。结论IL-5可能在转录和转录后水平均参与调节骨髓嗜酸粒细胞的功能和炎症细胞在肺和骨髓之间的转运。  相似文献   
5.
A close association has been recognized between activated T cells and eosinophils in asthma, albeit circumstantial. The present study attempted to investigate this relationship in an animal model of lung eosinophilia using the new generation of T cell-selective immunosuppressants, cyclosporin A and FK506, compared with the myelotoxic immunosuppressive agent cyclophosphamide. Antigen challenge of ovalbumin-sensitized guinea-pigs resulted in a lung eosinophilia which was assessed by bronchoalveolar lavage. All three agents caused a marked suppression of lung eosinophilia at 24 h post-challenge when the compounds were administered at the time of sensitization but not when administered for 3 days before lavage. However, the lung eosinophilia at 72 h post-challenge was reduced significantly by FK506 and by cyclophosphamide, but not by cyclosporin A, when the drugs were administered for 3 days, before lavage. These results strongly suggest the involvement of T cells in antigen-induced late phase (72 h) eosinophilia in guinea-pigs but not at 24 h. The effects of cyclophosphamide were always associated with a reduction in circulating white cell counts, whereas cyclosporin A and FK506 showed no myelotoxic properties. These results suggest the potential therapeutic use of selective, non-cytotoxic immunosuppressive agents in asthma.  相似文献   
6.
目的 了解嗜酸性粒细胞和支气管上皮细胞相互作用诱导细胞因子释放的p38 MAPK信号转导通路.方法 用CD16磁珠抗体分离外周血中嗜酸性粒细胞,以嗜酸性粒细胞和支气管上皮细胞(BEAS-2B)接触共培养为实验模型,观察SB 203580对细胞培养上清液中细胞因子浓度的影响.细胞因子浓度采用ELISA和流式细胞微珠方法测定.结果 SB 203580能够有效抑制BEAS-2B细胞释放IL-6、IL-8(P<0.05)和嗜酸性粒细胞释放IL-8(P<0.01).SB 203580对嗜酸性粒细胞与BEAS-2B细胞接触共培养诱导的IL-6、IL-8和IP-10释放具有显著抑制作用(P<0.001).结论 嗜酸性粒细胞、BEAS-2B细胞单独或相互作用时均通过p38 MAPK信号转导通路释放细胞因子.  相似文献   
7.
尾部悬吊与30月龄大鼠比目鱼肌的形态学特征比较   总被引:2,自引:0,他引:2  
目的 观察尾部悬吊和30月龄大鼠比目鱼肌发生萎缩过程的异同点.方法 SD雄性大鼠42只,随机分为7组,即尾部悬吊5 d、7 d、14 d组,相应的同步对照和30月鼠龄组,在各时间点制备比目鱼肌横截面冰冻切片标本,用抗MHC Ⅱ单克隆抗体进行免疫组织化学染色,计算比目鱼肌Ⅰ、Ⅱ型肌纤维横截面积并计数各型肌纤维数目.结果 与同步对照组相比,悬吊组大鼠比目鱼肌的湿重,相对湿重,Ⅰ、Ⅱ型肌纤维横截面积,经体重归一化的肌纤维横截面积均显著降低,Ⅱ型肌纤维比例显著增加,而Ⅰ型肌纤维比例减少.与14 d对照组相比,30月龄组大鼠比目鱼肌湿重和Ⅰ、Ⅱ型肌纤维横截面积均明显增大,但其相对湿重和经体重归一化的肌纤维横截面积却显著降低,与悬吊14 d组无显著差异.30月龄组大鼠比目鱼肌中Ⅰ、Ⅱ型肌纤维比例与各对照组相比亦无显著差异.结论 30月龄大鼠比目鱼肌萎缩以首先出现相对湿重与归一化肌纤维横截面积降低为特征,且发生较慢,而尾部悬吊大鼠比目鱼肌则在较短时间内发生全面萎缩.  相似文献   
8.
Background Eosinophil infiltration is a hallmark of the inflammatory response in rhinitis and in nasal polypcsis. Objective We studied the effect of steroids and nedocromil sodium on eosinophil survival primed by epithelial cells from healthy (nasal mucosa) and inflamed (nasal polyp) respiratory tissue. Methods Blood eosinophils were incubated with increasing concentrations (10-11 10-5 M) of topical steroids (fiuticasone propionate, budesonide, triamcinolone acetonide and beclomethasone dipropionate) and/or nedocromil sodium prior to the addition of human epithelial cell conditioned media (HECM), eosinophil viability was measured and IC50 for each drug was calculated. Results All four steroids and nedocromil sodium caused a dose-related inhibition of HECM-induced eosinophil survival. The IC50 of steroids were lower in eosinophils primed by mucosa HECM than on those primed by polyp HECM (fluticasone, 4nM vs 114nM: budesonide, 21 nM vs 280 nM; triamcinolone, 7 nM vs 853 nM; and beclomethasone, 171 nM vs 181 nM). The combined inhibitory effect of 10-7M budesonide plus 10-5M nedocromil (43.8 ± 10.8%, P < 0.03) was significantly higher than budesonide (28.5 ± 9.2%) or nedocromil (16.7 ± 5.4%) alone and close to 10-5M budesonide (52.3 ± 11%). No differences were found in cytokine (IL-8, IL-6, GM-CSF, TNFα, IL-lβ and RANTES) concentrations between HECM from mucosa and polyps. Conclusion These results suggest that topical anti-inflammatory drugs may diminish airway eosinophilic infiltration by decreasing eosinophil viability, that nasal polyp epithelial cell secretions may induce steroid resistance in eosinophils, and that nedocromil sodium has additive effects with steroids.  相似文献   
9.
本试验探讨了华南双季稻区利用亚种同杂种优势的特点和问题,结果表明:当前,两系亚种问杂种一代主要存在的问题是结实率低和谷草比低;籼粳交杂种易受环境条件的影响;每穗实粒数和单株有效穗数是决定单株产量的重要因子;每穗实粒数增加的关键在于结实率的提高,本文还就提高结实率和谷草比等问题提出了意见。  相似文献   
10.
应用Meta分析有效估计人群归因危险度百分比的探讨   总被引:2,自引:0,他引:2       下载免费PDF全文
人群归因危险度百分比 (populationattributableriskproportion ,PARP)是总体人群中某种疾病归因于某种因素的暴露所引起的发病 (死亡 )占全部发病 (死亡 )的百分比 ,反映该因素所引起的发病 (死亡 )占全部发病 (死亡 )的比重。通过PARP可了解各危险因素对人群中某疾病的发病所产生的影响 ,亦即消除某危险因素后 ,所产生的对预防该疾病的效果将占有多大比重。它能够为卫生政策的制订提供依据 ,有着重要的公共卫生的实际意义。目前常用的估计PARP的方法有两种 :一种是利用全国人群抽样调查获得的人群总暴露率来估计 ;另一种是利用某地区…  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号